Keywords
Last Name

Sherri O. Stuver, ScD

TitleAssociate Professor
InstitutionBoston University School of Public Health
DepartmentEpidemiology
Address715 Albany St Talbot Building
Boston MA 02118
Phone(617) 638-6724
ORCID ORCID Icon0000-0002-4027-2663
 Research Expertise & Professional Interests
Dr. Stuver's research has focused on virus-associated disease and malignancy, especially those related to hepatitis C virus and human T-lymphotropic virus type I infections. She was the principal investigator of a community-based cohort study in Japan investigating viral and nonviral risk factors for progression of hepatitis C virus infection to liver damage and hepatocellular carcinoma. She currently collaborates with Dr. Lisa Fredman on her studies of the effects of stress among older caregivers and non-caregivers. Dr. Stuver also is involved in research and quality improvement projects in the Department of Quality and Patient Safety at Dana-Farber Cancer Institute, including care at the end of life and the use of supportive therapies.

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Oda K, Uto H, Kumagai K, Ido A, Kusumoto K, Shimoda K, Hayashi K, Stuver SO, Tanaka Y, Nishida N, Tokunaga K, Tsubouchi H. Impact of a single nucleotide polymorphism upstream of the IL28B gene in patients positive for anti-HCV antibody in an HCV hyperendemic area in Japan. J Med Virol. 2014 Nov; 86(11):1877-85.
    View in: PubMed
  2. Rothman KJ, Stuver SO. In: Saracci R, Trichopoulos D, Olsen J, eds. Teaching Epidemiology. Fourth Edition. Teaching a first course in epidemiologic principles and methods. Oxford University Press. London. 2014; (In Press).
  3. Li JW, Morway L, Velasquez A, Weingart SN, Stuver SO. Perceptions of Medical Errors in Cancer Care: An Analysis of How the News Media Describe Sentinel Events. J Patient Saf. 2013 Sep 27.
    View in: PubMed
  4. Fredman L, Gordon SA, Heeren T, Stuver SO. Positive Affect Is Associated With Fewer Sleep Problems in Older Caregivers but not Noncaregivers. Gerontologist. 2014 Aug; 54(4):559-69.
    View in: PubMed
  5. Tsubouchi N, Uto H, Kumagai K, Sasaki F, Kanmura S, Numata M, Moriuchi A, Oketani M, Ido A, Hayashi K, Kusumoto K, Shimoda K, Stuver SO, Tsubouchi H. Impact of antibody to hepatitis B core antigen on the clinical course of hepatitis C virus carriers in a hyperendemic area in Japan: A community-based cohort study. Hepatol Res. 2013 Nov; 43(11):1130-8.
    View in: PubMed
  6. Edwards EM, Stuver SO, Heeren TC, Fredman L. Job strain and incident metabolic syndrome over 5 years of follow-up: the coronary artery risk development in young adults study. J Occup Environ Med. 2012 Dec; 54(12):1447-52.
    View in: PubMed
  7. Weingart SN, Cleary A, Scullion B, Morway L, Phantumvanit V, Stuver SO, Shulman LN, Connors JM. Comparing clinicians'' use of an anticoagulation management service and usual care in ambulatory oncology. J Oncol Pharm Pract. 2013 Sep; 19(3):237-45.
    View in: PubMed
  8. Reed C, Bliss C, Stuver SO, Heeren T, Tumilty S, Horsburgh CR, Samet JH, Cotton DJ. Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus. Am J Public Health. 2013 Jan; 103(1):105-11.
    View in: PubMed
  9. Isaac T, Stuver SO, Davis RB, Block S, Weeks JC, Berry DL, Weingart SN. Incidence of severe pain in newly diagnosed ambulatory patients with stage IV cancer. Pain Res Manag. 2012 Sep-Oct; 17(5):347-52.
    View in: PubMed
  10. Zhu J, Davis RB, Stuver SO, Berry DL, Block S, Weeks JC, Weingart SN. A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer. Cancer. 2012 Dec 15; 118(24):6278-86.
    View in: PubMed
  11. Weingart SN, Cleary A, Stuver SO, Lynch M, Brandoff D, Schaefer KG, Zhu J, Berry DL, Block S, Weeks JC. Assessing the quality of pain care in ambulatory patients with advanced stage cancer. J Pain Symptom Manage. 2012 Jun; 43(6):1072-81.
    View in: PubMed
  12. Imakiire K, Uto H, Sato Y, Sasaki F, Mawatari S, Ido A, Shimoda K, Hayashi K, Stuver SO, Ito Y, Okanoue T, Tsubouchi H. Difference in serum complement component C4a levels between hepatitis C virus carriers with persistently normal alanine aminotransferase levels or chronic hepatitis C. Mol Med Rep. 2012 Aug; 6(2):259-64.
    View in: PubMed
  13. Stuver SO, Isaac T, Weeks JC, Block S, Berry DL, Davis RB, Weingart SN. Factors associated with pain among ambulatory patients with cancer with advanced disease at a comprehensive cancer center. J Oncol Pract. 2012 Jul; 8(4):e17-23.
    View in: PubMed
  14. Weingart SN, Li JW, Zhu J, Morway L, Stuver SO, Shulman LN, Hassett MJ. US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards. J Oncol Pract. 2012 Jan; 8(1):7-12.
    View in: PubMed
  15. Stuver SO, Zhu J, Simchowitz B, Hassett MJ, Shulman LN, Weingart SN. Identifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf. 2011 Dec; 37(12):568-75.
    View in: PubMed
  16. Zhu J, Stuver SO, Epstein AM, Schneider EC, Weissman JS, Weingart SN. Can we rely on patients' reports of adverse events? Med Care. 2011 Oct; 49(10):948-55.
    View in: PubMed
  17. Omland LH, Jepsen P, Krarup H, Christensen PB, Weis N, Nielsen L, Obel N, Sørensen HT, Stuver SO. Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: results from the DANVIR cohort study. Int J Cancer. 2012 May 15; 130(10):2310-7.
    View in: PubMed
  18. Weingart SN, Zhu J, Chiappetta L, Stuver SO, Schneider EC, Epstein AM, David-Kasdan JA, Annas CL, Fowler FJ, Weissman JS. Hospitalized patients' participation and its impact on quality of care and patient safety. Int J Qual Health Care. 2011 Jun; 23(3):269-77.
    View in: PubMed
  19. Nunes D, Fleming C, Offner G, Craven D, Fix O, Heeren T, Koziel MJ, Graham C, Tumilty S, Skolnik P, Stuver S, Horsburgh CR, Cotton D. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol. 2010 Jun; 105(6):1346-53.
    View in: PubMed
  20. Kanmura S, Uto H, Sato Y, Kumagai K, Sasaki F, Moriuchi A, Oketani M, Ido A, Nagata K, Hayashi K, Stuver SO, Tsubouchi H. The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma. J Gastroenterol. 2010 Apr; 45(4):459-67.
    View in: PubMed
  21. Uto H, Stuver SO, Hayashi K, Kumagai K, Sasaki F, Kanmura S, Numata M, Moriuchi A, Hasegawa S, Oketani M, Ido A, Kusumoto K, Hasuike S, Nagata K, Kohara M, Tsubouchi H. Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study. Hepatology. 2009 Aug; 50(2):393-9.
    View in: PubMed
  22. Birmann BM, Breen EC, Stuver S, Cranston B, Martínez-Maza O, Falk KI, Okayama A, Hanchard B, Mueller N, Hisada M. Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica. Int J Cancer. 2009 Feb 1; 124(3):614-21.
    View in: PubMed
  23. Takahama Y, Uto H, Kanmura S, Oketani M, Ido A, Kusumoto K, Hasuike S, Nagata K, Hayashi K, Stuver S, Okayama A, Tsubouchi H. Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan. J Gastroenterol. 2008; 43(12):942-50.
    View in: PubMed
  24. Reed C, Stuver SO, Tumilty S, Nunes D, Murray JE, Graham CS, James Koziel M, Craven DE, Skolnik PR, Horsburgh CR. Predictors of treatment for hepatitis C virus (HCV) infection in drug users. Subst Abus. 2008; 29(1):5-15.
    View in: PubMed
  25. Uto H, Kurogi J, Takahama Y, Kusumoto K, Hayashi K, Ido A, Kohara M, Stuver SO, Moriuchi A, Hasegawa S, Oketani M, Tsubouchi H. Alanine aminotransferase flare-up in hepatitis C virus carriers with persistently normal alanine aminotransferase levels in a hyperendemic area of Japan. J Gastroenterol. 2007 Aug; 42(8):673-80.
    View in: PubMed
  26. Kanmura S, Uto H, Kusumoto K, Ishida Y, Hasuike S, Nagata K, Hayashi K, Ido A, Stuver SO, Tsubouchi H. Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system. Hepatology. 2007 Apr; 45(4):948-56.
    View in: PubMed
  27. Graham CS, Wells A, Edwards EM, Herren T, Tumilty S, Stuver SO, Samet JH, Nunes D, Horsburgh CR, Koziel MJ. Effect of exposure to injection drugs or alcohol on antigen-specific immune responses in HIV and hepatitis C virus coinfection. J Infect Dis. 2007 Mar 15; 195(6):847-56.
    View in: PubMed
  28. Suruki RY, Mueller N, Hayashi K, Harn D, DeGruttola V, Raker CA, Tsubouchi H, Stuver SO. Host immune status and incidence of hepatocellular carcinoma among subjects infected with hepatitis C virus: a nested case-control study in Japan. Cancer Epidemiol Biomarkers Prev. 2006 Dec; 15(12):2521-5.
    View in: PubMed
  29. Suruki R, Hayashi K, Kusumoto K, Uto H, Ido A, Tsubouchi H, Stuver SO. Alanine aminotransferase level as a predictor of hepatitis C virus-associated hepatocellular carcinoma incidence in a community-based population in Japan. Int J Cancer. 2006 Jul 1; 119(1):192-5.
    View in: PubMed
  30. Birmann BM, Mueller NE, Okayama A, Hsieh CC, Tsubouchi H, Harn D, Stuver SO. Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I. J Med Virol. 2006 Jun; 78(6):847-52.
    View in: PubMed
  31. Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, Stuver SO, Ido A, Tsubouchi H. Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine. 2006 Apr; 34(1-2):24-31.
    View in: PubMed
  32. Uto H, Hayashi K, Kusumoto K, Hasuike S, Nagata K, Kodama M, Ido A, Kohara M, Stuver SO, Tsubouchi H. Spontaneous elimination of hepatitis C virus RNA in individuals with persistent infection in a hyperendemic area of Japan. Hepatol Res. 2006 Jan; 34(1):28-34.
    View in: PubMed
  33. Tanaka G, Okayama A, Watanabe T, Aizawa S, Stuver S, Mueller N, Hsieh CC, Tsubouchi H. The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers. J Infect Dis. 2005 Apr 1; 191(7):1140-7.
    View in: PubMed
  34. Gao G, Stuver SO, Okayama A, Tsubouchi H, Mueller NE, Tabor E. The minimum number of clones necessary to sequence in order to obtain the maximum information about hepatitis C virus quasispecies: a comparison of subjects with and without liver cancer. J Viral Hepat. 2005 Jan; 12(1):46-50.
    View in: PubMed
  35. Hayashi K, Hasuike S, Kusumoto K, Ido A, Uto H, Kenji N, Kohara M, Stuver SO, Tsubouchi H. Usefulness of a new immuno-radiometric assay to detect hepatitis C core antigen in a community-based population. J Viral Hepat. 2005 Jan; 12(1):106-10.
    View in: PubMed
  36. Hisada M, Stuver SO, Okayama A, Li HC, Sawada T, Hanchard B, Mueller NE. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. J Infect Dis. 2004 Nov 1; 190(9):1605-9.
    View in: PubMed
  37. Birmann BM, Mueller N, Okayama A, Hsieh CC, Tachibana N, Tsubouchi H, Lennette ET, Harn D, Stuver S. Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults. Cancer Epidemiol Biomarkers Prev. 2004 Aug; 13(8):1385-91.
    View in: PubMed
  38. Okayama A, Stuver S, Matsuoka M, Ishizaki J, Tanaka G, Kubuki Y, Mueller N, Hsieh CC, Tachibana N, Tsubouchi H. Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers. Int J Cancer. 2004 Jul 1; 110(4):621-5.
    View in: PubMed
  39. Raker CA, Tabor E, Okayama A, Yu MY, Kohara M, Mueller NE, Tsubouchi H, Stuver SO. HCV core antigen as an alternative to NAT to detect HCV viremia. Transfusion. 2004 Feb; 44(2):307-8.
    View in: PubMed
  40. Romundstad PR, Vatten LJ, Nilsen TI, Holmen TL, Hsieh CC, Trichopoulos D, Stuver SO. Birth size in relation to age at menarche and adolescent body size: implications for breast cancer risk. Int J Cancer. 2003 Jun 20; 105(3):400-3.
    View in: PubMed
  41. Vatten LJ, Romundstad PR, Holmen TL, Hsieh CC, Trichopoulos D, Stuver SO. Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring. Obstet Gynecol. 2003 Mar; 101(3):529-33.
    View in: PubMed
  42. Lewis-Ximenez LL, do O KM, Ginuino CF, Silva JC, Schatzmayr HG, Stuver S, Yoshida CF. Risk factors for hepatitis B virus infection in Rio de Janeiro, Brazil. BMC Public Health. 2002 Nov 22; 2:26.
    View in: PubMed
  43. Iga M, Okayama A, Stuver S, Matsuoka M, Mueller N, Aoki M, Mitsuya H, Tachibana N, Tsubouchi H. Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses. J Infect Dis. 2002 Mar 1; 185(5):691-5.
    View in: PubMed
  44. Vatten LJ, Maehle BO, Lund Nilsen TI, Tretli S, Hsieh CC, Trichopoulos D, Stuver SO. Birth weight as a predictor of breast cancer: a case-control study in Norway. Br J Cancer. 2002 Jan 7; 86(1):89-91.
    View in: PubMed
  45. Okayama A, Stuver SO, Tabor E, Tachibana N, Kohara M, Mueller NE, Tsubouchi H. Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepat. 2002 Jan; 9(1):43-51.
    View in: PubMed
  46. Arduino JM, Stuver SO, Spiegelman D, Okayama A, Tabor E, Yu MW, Kohara M, Tsubouchi H, Mueller NE. Assessment of markers of hepatitis C virus infection in a Japanese adult population. J Infect Dis. 2001 Nov 15; 184(10):1229-35.
    View in: PubMed
  47. Okayama A, Stuver S, Iga M, Okamoto M, Mueller N, Matsuoka M, Yamaguchi K, Tachibana N, Tsubouchi H. Sequential change of virus markers in seroconverters with community-acquired infection of human T lymphotropic virus type I. J Infect Dis. 2001 Apr 1; 183(7):1031-7.
    View in: PubMed
  48. Hisada M, Okayama A, Spiegelman D, Mueller NE, Stuver SO. Sex-specific mortality from adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Int J Cancer. 2001 Feb 15; 91(4):497-9.
    View in: PubMed
  49. Kuper H, Mantzoros C, Lagiou P, Tzonou A, Tamimi R, Mucci L, Benetou V, Spanos E, Stuver SO, Trichopoulos D. Estrogens, testosterone and sex hormone binding globulin in relation to liver cancer in men. Oncology. 2001; 60(4):355-60.
    View in: PubMed
  50. Lewis-Ximenez LL, Oliveira JM, Mercadante LA, De Castro L, Santa Catharina W, Stuver S, Yoshida CF. Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection. Nephron. 2001 Jan; 87(1):19-26.
    View in: PubMed
  51. Stuver SO, Tanaka K, Ikematsu H, Okayama A, Tachibana N, Hirohata T, Kashiwagi S, Tsubouchi H, Mueller N. Re: "Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan". Int J Cancer. 2000 Dec 1; 88(5):833-4.
    View in: PubMed
  52. Kuper H, Hsieh C, Stuver SO, Mucci LA, Tzonou A, Zavitsanos X, Lagiou P, Trichopoulos D. Birth order, as a proxy for age at infection, in the etiology of hepatocellular carcinoma. Epidemiology. 2000 Nov; 11(6):680-3.
    View in: PubMed
  53. Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D, Adami HO. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst. 2000 Jul 5; 92(13):1096-9.
    View in: PubMed
  54. Stuver SO, Kuper H, Tzonou A, Lagiou P, Spanos E, Hsieh CC, Mantzoros C, Trichopoulos D. Insulin-like growth factor 1 in hepatocellular carcinoma and metastatic liver cancer in men. Int J Cancer. 2000 Jul 1; 87(1):118-21.
    View in: PubMed
  55. Stuver SO, Boschi-Pinto C, Okayama A, Mueller N. Reply J Infect Dis. 2000 Jul; 182(1):379-80.
    View in: PubMed
  56. Abtahi A, Mueller N, Okayama A, Stuver S. Lack of evidence for a role of HTLV-I infection in the occurrence of subclinical HAM/TSP in the Miyazaki Cohort Study. J Acquir Immune Defic Syndr. 2000 May 1; 24(1):86-7.
    View in: PubMed
  57. Kuper H, Tzonou A, Kaklamani E, Hsieh CC, Lagiou P, Adami HO, Trichopoulos D, Stuver SO. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer. 2000 Feb 15; 85(4):498-502.
    View in: PubMed
  58. Kuper HE, Tzonou A, Kaklamani E, Hadziyannis S, Tasopoulos N, Lagiou P, Trichopoulos D, Stuver S. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays. Cancer Causes Control. 2000 Feb; 11(2):171-5.
    View in: PubMed
  59. Boschi-Pinto C, Stuver S, Okayama A, Trichopoulos D, Orav EJ, Tsubouchi H, Mueller N. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan. J Infect Dis. 2000 Jan; 181(1):35-41.
    View in: PubMed
  60. Kuper H, Tzonou A, Lagiou P, Mucci LA, Trichopoulos D, Stuver SO, Trichopoulou A. Diet and hepatocellular carcinoma: a case-control study in Greece. Nutr Cancer. 2000; 38(1):6-12.
    View in: PubMed
  61. Hisada M, Stuver SO, Okayama A, Mueller NE. Gender difference in skin reactivity to purified protein derivative among carriers of HTLV-I in Japan. J Acquir Immune Defic Syndr. 1999 Nov 1; 22(3):302-7.
    View in: PubMed
  62. Etoh K, Yamaguchi K, Tokudome S, Watanabe T, Okayama A, Stuver S, Mueller N, Takatsuki K, Matsuoka M. Rapid quantification of HTLV-I provirus load: detection of monoclonal proliferation of HTLV-I-infected cells among blood donors. Int J Cancer. 1999 Jun 11; 81(6):859-64.
    View in: PubMed
  63. Hisada M, Shima T, Okayama A, Mueller N, Tsubouchi H, Stuver S. Suppression of skin reactivity to purified protein derivative by hepatitis C virus among HTLV-I carriers in Japan. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1; 19(4):421-5.
    View in: PubMed
  64. Hisada M, Okayama A, Shioiri S, Spiegelman DL, Stuver SO, Mueller NE. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Blood. 1998 Nov 15; 92(10):3557-61.
    View in: PubMed
  65. Stuver SO. Towards global control of liver cancer? Semin Cancer Biol. 1998 Aug; 8(4):299-306.
    View in: PubMed
  66. Hisada M, Okayama A, Tachibana N, Stuver SO, Spiegelman DL, Tsubouchi H, Mueller NE. Predictors of level of circulating abnormal lymphocytes among human T-lymphotropic virus type I carriers in Japan. Int J Cancer. 1998 Jul 17; 77(2):188-92.
    View in: PubMed
  67. Shioiri S, Stuver SO, Okayama A, Murai K, Shima T, Tachibana N, Tsubouchi H, Essex M, Mueller N. Intrafamilial transmission of HTLV-I and its association with anti-Tax antibody in an endemic population in Japan. Int J Cancer. 1998 Jan 5; 75(1):15-8.
    View in: PubMed
  68. Tanaka K, Stuver SO, Ikematsu H, Okayama A, Tachibana N, Hirohata T, Kashiwagi S, Tsubouchi H, Mueller NE. Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan. Int J Cancer. 1997 Jul 3; 72(1):50-5.
    View in: PubMed
  69. Okayama A, Tachibana N, Ishihara S, Nagatomo Y, Murai K, Okamoto M, Shima T, Sagawa K, Tsubouchi H, Stuver S, Mueller N. Increased expression of interleukin-2 receptor alpha on peripheral blood mononuclear cells in HTLV-I tax/rex mRNA-positive asymptomatic carriers. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 May 1; 15(1):70-5.
    View in: PubMed
  70. Stuver SO, Hsieh CC, Bertone E, Trichopoulos D. The association between lactation and breast cancer in an international case-control study: a re-analysis by menopausal status. Int J Cancer. 1997 Apr 10; 71(2):166-9.
    View in: PubMed
  71. Stuver SO, Boschi-Pinto C, Trichopoulos D. Infection with hepatitis B and C viruses, social class and cancer. IARC Sci Publ. 1997; (138):319-24.
    View in: PubMed
  72. Stuver SO, Okayama A, Tachibana N, Tsubouchi H, Mueller NE, Tabor E. HCV infection and liver cancer mortality in a Japanese population with HTLV-I. Int J Cancer. 1996 Jul 3; 67(1):35-7.
    View in: PubMed
  73. Stuver SO, Tachibana N, Okayama A, Mueller NE. Evaluation of morbidity among human T lymphotropic virus type 1 carriers in Miyazaki, Japan. J Infect Dis. 1996 Mar; 173(3):584-91.
    View in: PubMed
  74. Katsouyanni K, Lipworth L, Trichopoulou A, Samoli E, Stuver S, Trichopoulos D. A case-control study of lactation and cancer of the breast. Br J Cancer. 1996 Mar; 73(6):814-8.
    View in: PubMed
  75. Mueller N, Okayama A, Stuver S, Tachibana N. Findings from the Miyazaki Cohort Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 13 Suppl 1:S2-7.
    View in: PubMed
  76. Stuver SO, Mueller NE. Re: "Sexual transmission of human T-lymphotropic virus type I among female prostitutes and among patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan". Am J Epidemiol. 1995 Dec 1; 142(11):1247-8.
    View in: PubMed
  77. Lipworth L, Katsouyanni K, Stuver S, Samoli E, Hankinson SE, Trichopoulos D. Oral contraceptives, menopausal estrogens, and the risk of breast cancer: a case-control study in Greece. Int J Cancer. 1995 Sep 4; 62(5):548-51.
    View in: PubMed
  78. Hadziyannis S, Tabor E, Kaklamani E, Tzonou A, Stuver S, Tassopoulos N, Mueller N, Trichopoulos D. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma. Int J Cancer. 1995 Mar 3; 60(5):627-31.
    View in: PubMed
  79. Trichopoulou A, Katsouyanni K, Stuver S, Tzala L, Gnardellis C, Rimm E, Trichopoulos D. Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. J Natl Cancer Inst. 1995 Jan 18; 87(2):110-6.
    View in: PubMed
  80. Katsouyanni K, Trichopoulou A, Stuver S, Garas Y, Kritselis A, Kyriakou G, Stoïkidou M, Boyle P, Trichopoulos D. The association of fat and other macronutrients with breast cancer: a case-control study from Greece. Br J Cancer. 1994 Sep; 70(3):537-41.
    View in: PubMed
  81. Katsouyanni K, Trichopoulou A, Stuver S, Vassilaros S, Papadiamantis Y, Bournas N, Skarpou N, Mueller N, Trichopoulos D. Ethanol and breast cancer: an association that may be both confounded and causal. Int J Cancer. 1994 Aug 1; 58(3):356-61.
    View in: PubMed
  82. Ishihara S, Okayama A, Stuver S, Horinouchi H, Shioiri S, Murai K, Kubota T, Yamashita R, Tachibana N, Tsubouchi H, et al. Association of HTLV-I antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells. J Acquir Immune Defic Syndr. 1994 Feb; 7(2):199-203.
    View in: PubMed
  83. Stuver SO, Trichopoulos D. Liver cancer. Cancer Surv. 1994; 19-20:99-124.
    View in: PubMed
  84. Shioiri S, Tachibana N, Okayama A, Ishihara S, Tsuda K, Essex M, Stuver SO, Mueller N. Analysis of anti-Tax antibody of HTLV-I carriers in an endemic area in Japan. Int J Cancer. 1993 Jan 2; 53(1):1-4.
    View in: PubMed
  85. Stuver SO, Tachibana N, Okayama A, Shioiri S, Tsunetoshi Y, Tsuda K, Mueller NE. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis. 1993 Jan; 167(1):57-65.
    View in: PubMed
  86. Tachibana N, Okayama A, Ishihara S, Shioiri S, Murai K, Tsuda K, Goya N, Matsuo Y, Essex M, Stuver S, et al. High HTLV-I proviral DNA level associated with abnormal lymphocytes in peripheral blood from asymptomatic carriers. Int J Cancer. 1992 Jun 19; 51(4):593-5.
    View in: PubMed
  87. Stuver SO, Tachibana N, Mueller N. Case-control study of factors associated with human T-cell leukemia virus type I infection in southern Miyazaki, Japan. J Natl Cancer Inst. 1992 Jun 3; 84(11):867-72.
    View in: PubMed
  88. Stuver SO, Tachibana N, Okayama A, Romano F, Yokota T, Mueller N. Determinants of HTLV-1 seroprevalence in Miyazaki Prefecture, Japan: a cross-sectional study. J Acquir Immune Defic Syndr. 1992; 5(1):12-8.
    View in: PubMed
Sherri's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department